Close

Cowen Downgrades Orphazyme A/S (ORPHA:DC) (ORPH) to Market Perform, After Receiving FDA CRL

Go back to Cowen Downgrades Orphazyme A/S (ORPHA:DC) (ORPH) to Market Perform, After Receiving FDA CRL
(NASDAQ: ORPH) Delayed: 0.87 --0 (-0%)
Previous Close $0.87    52 Week High
Open $0.87    52 Week Low
Day High $0.87    P/E N/A 
Day Low $0.87    EPS
Volume 64,533